Diphenylpyrazone en es it fr

Diphenylpyrazone Brand names, Diphenylpyrazone Analogs

Diphenylpyrazone Brand Names Mixture

  • No information avaliable

Diphenylpyrazone Chemical_Formula


Diphenylpyrazone RX_link


Diphenylpyrazone fda sheet

Diphenylpyrazone msds (material safety sheet)

Diphenylpyrazone Synthesis Reference

No information avaliable

Diphenylpyrazone Molecular Weight

404.483 g/mol

Diphenylpyrazone Melting Point

136-137 oC

Diphenylpyrazone H2O Solubility

31.2 mg/L

Diphenylpyrazone State


Diphenylpyrazone LogP


Diphenylpyrazone Dosage Forms

100-mg tablets and 200-mg capsules for oral administration

Diphenylpyrazone Indication

For the treatment of gout and gouty arthritis.

Diphenylpyrazone Pharmacology

Sulfinpyrazone's pharmacologic activity is the potentiation of the urinary excretion of uric acid. It is useful for reducing the blood urate levels in patients with chronic tophaceous gout and acute intermittent gout, and for promoting the resorption of tophi.

Diphenylpyrazone Absorption

No information avaliable

Diphenylpyrazone side effects and Toxicity

Symptoms of overdose include nausea, vomiting, diarrhea, epigastric pain, ataxia, labored respiration, convulsions, coma. Possible symptoms, seen after overdosage with other pyrazolone derivatives: anemia, jaundice, and ulceration.

Diphenylpyrazone Patient Information

No information avaliable

Diphenylpyrazone Organisms Affected

Humans and other mammals